•Predictors of ustekinumab intensified dose escalation in inflammatory bowel disease: a real-world (UST-predict) study
•Evaluation of the immunomodulatory effects of novel phosphinic acid derivatives in vitro and in a murine colitis model
•Discovery of a gut-restricted LANCL2 agonist for the treatment of inflammatory bowel disease
•Evaluating the analgesic effect of metamizole in the mouse model for DSS-induced acute colitis
•Intestinal flagellin drives multisystem inflammation through TLR5-IL-15-ARA axis
